A case of sodium oxybate treatment of tardive dyskinesia and bipolar disorder

Journal of Clinical Psychiatry

Volumn 69, Issue 5, 2008, Pages 862-

  Berner, Jon E ^a  

^a Woodinville Psychiatric Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZATROPINE; HYDROCODONE; OLANZAPINE; OXYBATE SODIUM;

ADULT; ANAMNESIS; ANKYLOSING SPONDYLITIS; BIPOLAR DISORDER; CASE REPORT; DISEASE COURSE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FIBROMYALGIA; HUMAN; LETTER; MOOD; MOOD DISORDER; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; TARDIVE DYSKINESIA;

EID: 45249108677     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0522a     Document Type: Letter

References (5)

1. Scharf MB, Baumann M, Berkowitz DV. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol 2003 May;30(5):1070-1074
2. Wallace DJ, Gotto J. Hypothesis: bipolar illness with complaints of chronic musculoskeletal pain is a form of pseudofibromyalgia. Semin Arthritis Rheum 2008 Feb;37(4):256-259
3. Kemmel V, Miehe M, Roussel G, et al. Immunohistochemical localization of a GHB receptor-like protein isolated from rat brain. J Comp Neurol 2006 Oct;498(4):508-524
4. Johnson DT, Harris RA, Blair PV, et al. Functional consequences of mitochondrial proteome heterongeneity. Am J Physiol Cell Physiol 2007 Feb;292(2):C698-C707
5. Fattal O, Link J, Quinn K, et al. Psychiatric comorbidity in 36 adults with mitochondrial cytopathies. CNS Spectr 2007 Jun;12(6):429-438